Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C27H25F3N2O |
| Molecular Weight | 450.4954 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(CCCN1CCC2=C(C1)C3=C(C=CC(F)=C3)N2C4=CC=C(F)C=C4)C5=CC=C(F)C=C5
InChI
InChIKey=OYGDOCFZQVGFIP-UHFFFAOYSA-N
InChI=1S/C27H25F3N2O/c28-19-5-3-18(4-6-19)27(33)2-1-14-31-15-13-26-24(17-31)23-16-21(30)9-12-25(23)32(26)22-10-7-20(29)8-11-22/h3-12,16,27,33H,1-2,13-15,17H2
Flutroline, an antipsychotic drug that was studied to treat patients with schizophrenia. Clinical trials have shown that the drug was a safe, effective, and 20 mg and above offered the best potential for optimal clinical effectiveness. However, information about the further development of this drug is not available.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6141186
in single daily dosages of 1, 5, 10, 20, and 100 mg to 48 hospitalized schizophrenic patients over a period of four weeks
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB07766MIG
Created by
admin on Wed Apr 02 09:38:29 GMT 2025 , Edited by admin on Wed Apr 02 09:38:29 GMT 2025
|
PRIMARY | |||
|
C026240
Created by
admin on Wed Apr 02 09:38:29 GMT 2025 , Edited by admin on Wed Apr 02 09:38:29 GMT 2025
|
PRIMARY | |||
|
70801-02-4
Created by
admin on Wed Apr 02 09:38:29 GMT 2025 , Edited by admin on Wed Apr 02 09:38:29 GMT 2025
|
PRIMARY | |||
|
51174
Created by
admin on Wed Apr 02 09:38:29 GMT 2025 , Edited by admin on Wed Apr 02 09:38:29 GMT 2025
|
PRIMARY | |||
|
100000080426
Created by
admin on Wed Apr 02 09:38:29 GMT 2025 , Edited by admin on Wed Apr 02 09:38:29 GMT 2025
|
PRIMARY | |||
|
J922111J7P
Created by
admin on Wed Apr 02 09:38:29 GMT 2025 , Edited by admin on Wed Apr 02 09:38:29 GMT 2025
|
PRIMARY | |||
|
CHEMBL57241
Created by
admin on Wed Apr 02 09:38:29 GMT 2025 , Edited by admin on Wed Apr 02 09:38:29 GMT 2025
|
PRIMARY | |||
|
C169998
Created by
admin on Wed Apr 02 09:38:29 GMT 2025 , Edited by admin on Wed Apr 02 09:38:29 GMT 2025
|
PRIMARY | |||
|
DTXSID30867946
Created by
admin on Wed Apr 02 09:38:29 GMT 2025 , Edited by admin on Wed Apr 02 09:38:29 GMT 2025
|
PRIMARY | |||
|
4816
Created by
admin on Wed Apr 02 09:38:29 GMT 2025 , Edited by admin on Wed Apr 02 09:38:29 GMT 2025
|
PRIMARY |
ACTIVE MOIETY